metoprolol has been researched along with Retinal Pigment Epithelial Detachment in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dmuchowska, DA | 1 |
| Zalewska, R | 1 |
| Jasiewicz, M | 1 |
| Krasnicki, P | 1 |
| Mikita, A | 1 |
| Sobkowicz, B | 1 |
| Mariak, Z | 1 |
| Sarraf, D | 1 |
| Avci, R | 1 |
| Deutman, AF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Oral Mifepristone for Central Serous Chorioretinopathy. A Placebo-controlled Dose Ranging Study of Mifepristone in the Treatment of CSC (STOMP-CSC)[NCT02354170] | Phase 2 | 16 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for metoprolol and Retinal Pigment Epithelial Detachment
| Article | Year |
|---|---|
Diagnostic and Therapeutic Challenges.
Topics: Amlodipine; Antihypertensive Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Hum | 2015 |
[Treatment of central serous choroidopathy with the beta receptor blocker metoprolol (preliminary results)].
Topics: Administration, Oral; Adult; Chorioretinitis; Dose-Response Relationship, Drug; Drug Administration | 1993 |